|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The treatment of cardiovascular disease continuum:focus on prevention and RAS blockade显示文摘 | Chrysant S G Chrysant G S Chrysant C | 2010 | Curr Clin Pharmacol2010，5，2： | 1 |
| 2 | Comparative efficacy of olmesartan,losartan,Valsartan,and Lrbesartan in the control of essentlal hypertenslon显示文摘 | Oparll S williams D chrysant SG | 2001 | J Clin Hypertens(Greenwich)2001，3，29： | 1 |
| 3 | Chrysant, Clinical implications of cardiovascular preventing pleiotropic effects of dipeptidyl peptidase-4 inhibitors 显示文摘 | Chrysant S G Chrysant G S | 2012 | Am JCardiol2012，109，11： | 1 |
| 4 | The importance of early antihypertensive efficacy:the role of angiotensin II receptor blocker therapy显示文摘 | Basile JN Chrysant S | 2006 | J Hum Hypertens2006，20，3： | 1 |
| 5 | Antihypertensive efficacy and safety of olmesartan medoxomil compered with amlodipine for mild-to-moderate hypertension显示文摘 | Chrysant S G Marbury T C Robinson T D | 2003 | J Hum Hyperten2003，17，6： | 1 |
| 6 | Effectiveness of the fixed-dose combi- nation of olmesartan amlodipine hydrochlorothiazide for the treatment of hypertension in patients stratified by age, race and diabetes, CKD and chronic CVD显示文摘 | CHRYSANT S G | 2013 | Expert Rev Car- diovasc Ther2013，11，9： | 1 |
| 7 | The combination of olme- sartan medoxomil and amlodipine besylate in controlling high- blood pressure:COACH,a randomized ouble-blind lacebo-con- trolled,8-week factorial efficacy and safety study显示文摘 | Chrysant S Melino M Karki S | 2008 | Clin T- her2008，30，4： | 1 |
| 8 | Comparative efficacy of olmesartan, losartan, valsartan and irbesartan in the control of essential hypertension 显示文摘 | Oparils Williams D Chrysant S G | 2001 | J Clin Hypertens2001，3，5： | 1 |
| 9 | The effect of vardenafil,a se- lective PDE5 inhibitor,on ischemic threshold,exercise tolerance, and circulatory responses during treadmill exercise in men with stable angina pectoris 显示文摘 | Thadani U Chrysant S Mazzu A | 2003 | J Am Coil Cardiol2003，41，6： | 1 |
| 10 | The effect of vardenafil,a selective PDE5 inhibitor, on ischemic threshold, exercise tolerance, and circulatory responses during treadmill exercise in man with stable angina pectoris显示文摘 | Tbadani U Chrysant S Mazzu A | 2003 | J Am Coll Card iol2003，41，6： | 1 |
| 11 | The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double - blind, placebo - controlled, 8 - week factorial efficacy and safety study 显示文摘 | Chrysant SG Melino M Karki S | 2008 | Clin Ther2008，30，4： | 1 |
| 12 | Comparative ef- ficacy of olmesartan, losartan, valsartan and irbesartan in the control of essential hypertension显示文摘 | OpariI S Williams D Chrysant S | 2001 | J Clin Hy- pertens2001，3，10： | 1 |
| 13 | Coronary artery stent patency assessed with in-stent contrast enhancement measured at multidetector row CT angiography:initial experience显示文摘 | Hong C Chrysant G S Woodard P K | 2004 | Radiology2004，233，1： | 1 |
| 14 | Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension显示文摘 | OPARIL S WILLIAMS D CHRYSANT SG | 2001 | J Clin Hypertens2001，3，5： | 1 |
| 15 | Comparative efficacvolmesartan,loaartan,valmrtan and irbesartan in the control essential hypertension显示文摘 | Opafil S Williams D Chrysant sG | 2001 | J Clin Hypertem2001，3，5： | 1 |
| 16 | Coronary artery stent patency assessed with in-stent contrast enhancement measured at multi-detector row CT angiography: initial experience 显示文摘 | Hong C Chrysant G S Woodard P K | 2004 | Radiology2004，233，： | 1 |
| 17 | Comparative efficacy of olmcsartan, losartan, valsartan and irbesartan in the control of essential hypertension显示文摘 | Oparil S Williams D Chrysant S | 2001 | J Clin Hypertens2001，3，： | 1 |
| 18 | The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure : COACH, a randomized, double - blind, placebo - controlled,8- week factorial efficacy and safety study显示文摘 | CHRYSANT SG MELINO M KARKI S | 2008 | Clin Ther2008，30，4： | 1 |
| 19 | Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide 显示文摘 | VILLAMIL A CHRYSANT S G CALHOUN D | 2007 | Hypertens2007，25，1： | 1 |
| 20 | The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebocontrolled,8-week factorial efficacy and safety study显示文摘 | Chrysant S Melino M Karki S | 2008 | Clin Ther2008，30，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员